Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F5MZ
|
|||
Former ID |
DNC011152
|
|||
Drug Name |
4-(2'-(trifluoromethyl)biphenyl-3-yl)oxazole
|
|||
Synonyms |
CHEMBL1224519; BDBM50325801
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H10F3NO
|
|||
Canonical SMILES |
C1=CC=C(C(=C1)C2=CC(=CC=C2)C3=COC=N3)C(F)(F)F
|
|||
InChI |
1S/C16H10F3NO/c17-16(18,19)14-7-2-1-6-13(14)11-4-3-5-12(8-11)15-9-21-10-20-15/h1-10H
|
|||
InChIKey |
SRZDIBWHWBVAAW-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated sodium channel alpha Nav1.7 (SCN9A) | Target Info | Inhibitor | [1] |
Reactome | Interaction between L1 and Ankyrins |
References | Top | |||
---|---|---|---|---|
REF 1 | Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5536-40. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.